{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T12:55:53Z","timestamp":1726491353181},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jmb.2011.03.012","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T14:23:01Z","timestamp":1311344581000},"page":"1052-1064","source":"Crossref","is-referenced-by-count":4,"title":["HIV-1 Replication in Monocyte-derived Dendritic Cells is Stimulated by Melarsoprol, One of the Main Drugs Against Human African Trypanosomiasis"],"prefix":"10.1016","volume":"410","author":[{"given":"Corinne","family":"Barat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Pepin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel J.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2011.03.012_bb0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.21429","article-title":"The continuing problem of human African trypanosomiasis (sleeping sickness)","volume":"64","author":"Kennedy","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0010","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1371\/journal.pmed.0050055","article-title":"Eliminating human African trypanosomiasis: where do we stand and what comes next?","volume":"5","author":"Simarro","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.jmb.2011.03.012_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.1992.47.133","article-title":"The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki","volume":"47","author":"Pepin","year":"1992","journal-title":"Zaire. Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jmb.2011.03.012_bb0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-3156.2001.00710.x","article-title":"Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis","volume":"6","author":"Blum","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.jmb.2011.03.012_bb0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2011.03.012_bb0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2011.03.012_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"Pepin","year":"1994","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","article-title":"Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis","volume":"90","author":"Nok","year":"2003","journal-title":"Parasitol Res."},{"key":"10.1016\/j.jmb.2011.03.012_bb0050","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1128\/JVI.77.5.3167-3180.2003","article-title":"As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity","volume":"77","author":"Berthoux","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0055","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/JVI.80.4.2051-2054.2006","article-title":"Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner","volume":"80","author":"Sebastian","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1097-2765(01)00255-6","article-title":"Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication","volume":"7","author":"Turelli","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2011.03.012_bb0065","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1128\/JVI.00800-07","article-title":"Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells","volume":"81","author":"Pion","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/510398","article-title":"HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis","volume":"195","author":"Barat","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2011.03.012_bb0075","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.166.6.3780","article-title":"The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication","volume":"166","author":"Bakri","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0080","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.80.4.1992-1999.2006","article-title":"Human immunodeficiency virus fusion to dendritic cells declines as cells mature","volume":"80","author":"Cavrois","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.jid.5700518","article-title":"Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels","volume":"127","author":"Pion","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0090","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt745","article-title":"A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes","volume":"20","author":"Cavrois","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0095","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1084\/jem.20061519","article-title":"APOBEC3G\/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection","volume":"203","author":"Pion","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jmb.2011.03.012_bb0100","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.00023-08","article-title":"Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G","volume":"83","author":"Trapp","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0105","doi-asserted-by":"crossref","first-page":"9754","DOI":"10.1128\/JVI.01052-06","article-title":"Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins","volume":"80","author":"Anderson","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0110","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/JVI.72.5.3845-3850.1998","article-title":"Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1","volume":"72","author":"Schwartz","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0115","doi-asserted-by":"crossref","first-page":"e1000231","DOI":"10.1371\/journal.ppat.1000231","article-title":"APOBEC3G inhibits elongation of HIV-1 reverse transcripts","volume":"4","author":"Bishop","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2011.03.012_bb0120","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/JVI.02347-08","article-title":"Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection","volume":"83","author":"Okeoma","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood-2006-10-051763","article-title":"Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression","volume":"110","author":"Peng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2011.03.012_bb0130","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1128\/JVI.01089-09","article-title":"Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets","volume":"83","author":"Koning","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0135","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/blood-2008-10-185728","article-title":"Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation","volume":"113","author":"Ogawa","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2011.03.012_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20051512","article-title":"Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity","volume":"203","author":"Peng","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jmb.2011.03.012_bb0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1099\/vir.0.83530-0","article-title":"APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells","volume":"89","author":"Wang","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0150","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1189\/jlb.0310176","article-title":"Arsenic modulates APOBEC3G-mediated restriction to HIV-1 infection in myeloid dendritic cells","volume":"88","author":"Stalder","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0155","first-page":"1041","article-title":"Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients","volume":"59","author":"Rousselot","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jmb.2011.03.012_bb0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.taap.2010.02.012","article-title":"Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells","volume":"244","author":"Sumi","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0165","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.tiv.2009.11.011","article-title":"Syk is a novel target of arsenic trioxide (ATO) and is involved in the toxic effect of ATO in human neutrophils","volume":"24","author":"Antoine","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.jmb.2011.03.012_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/187152809787582516","article-title":"Interaction between arsenic trioxide and human primary cells: emphasis on human cells of myeloid origin","volume":"8","author":"Binet","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.jmb.2011.03.012_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000239130","article-title":"Pharmacokinetic properties of the trypanocidal drug melarsoprol","volume":"39","author":"Burri","year":"1993","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jmb.2011.03.012_bb0180","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-3156.2001.00725.x","article-title":"Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment","volume":"6","author":"Burri","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.jmb.2011.03.012_bb0185","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1073\/pnas.0936469100","article-title":"Tracing the origin and history of the HIV-2 epidemic","volume":"100","author":"Lemey","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2011.03.012_bb0190","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.aids.0000232239.05545.33","article-title":"Parenteral transmission during excision and treatment of tuberculosis and trypanosomiasis may be responsible for the HIV-2 epidemic in Guinea-Bissau","volume":"20","author":"Pepin","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jmb.2011.03.012_bb0195","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4049\/jimmunol.178.5.2862","article-title":"Involvement of Src and Syk tyrosine kinases in HIV-1 transfer from dendritic cells to CD4+ T lymphocytes","volume":"178","author":"Gilbert","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0200","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1128\/JVI.02810-06","article-title":"Human immunodeficiency virus type 1 replication in dendritic cell-T-cell cocultures is increased upon incorporation of host LFA-1 due to higher levels of virus production in immature dendritic cells","volume":"81","author":"Gilbert","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0205","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/588146","article-title":"Leishmania infantum promastigotes reduce entry of HIV-1 into macrophages through a lipophosphoglycan-mediated disruption of lipid rafts","volume":"197","author":"Garg","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2011.03.012_bb0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability","volume":"12","author":"Stopak","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2011.03.012_bb0215","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/JVI.71.3.1922-1930.1997","article-title":"The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity","volume":"71","author":"Cantin","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/viro.1998.9465","article-title":"HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission","volume":"253","author":"Dornadula","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2011.03.012_bb0225","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/JVI.66.6.3531-3537.1992","article-title":"Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4","volume":"66","author":"Clapham","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0230","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/JVI.76.3.1004-1014.2002","article-title":"Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo","volume":"76","author":"Bounou","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2011.03.012_bb0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1025732728195","article-title":"Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells","volume":"27","author":"Suzuki","year":"2003","journal-title":"Virus Genes"},{"key":"10.1016\/j.jmb.2011.03.012_bb0240","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90802-L","article-title":"HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure","volume":"61","author":"Zack","year":"1990","journal-title":"Cell"}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283611002774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283611002774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T10:34:07Z","timestamp":1592735647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283611002774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022283611002774"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2011.03.012","relation":{},"ISSN":["0022-2836"],"issn-type":[{"type":"print","value":"0022-2836"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}